(Q36732005)

15 August 2017

1 reference

title

Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets (English)

1 reference

15 August 2017

Abhinav Diwan

1

1 reference

15 August 2017

Gerald W Dorn

series ordinal

2

1 reference

15 August 2017

publication date

1 February 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

22

1 reference

15 August 2017

page(s)

56-64

1 reference

The Bcl-2 protein family: arbiters of cell survival

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Control of cardiac growth by histone acetylation/deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

The mitochondrial death pathway and cardiac myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Autophagy: in sickness and in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Transgenic Galphaq overexpression induces cardiac contractile failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Myocyte-restricted focal adhesion kinase deletion attenuates pressure overload-induced hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Gq signaling in cardiac adaptation and maladaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Protein kinase cascades in the regulation of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Death begets failure in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Cardiac hypertrophy: the good, the bad, and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Wall stress and patterns of hypertrophy in the human left ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Deletion of cytosolic phospholipase A2 promotes striated muscle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Negative regulators of cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Targeted inhibition of calcineurin in pressure-overload cardiac hypertrophy. Preservation of systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

The role of autophagy during the early neonatal starvation period

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Development by self-digestion: molecular mechanisms and biological functions of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Programmed cell death and apoptosis: origins of the theory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Death by design. Programmed cell death in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Nuclear apoptotic changes: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Autophagosome formation in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

The effect of physical training upon the mechanical and metabolic performance of the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

The role of BH3-only proteins in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Prognostic implications of left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Cardiovascular pharmacology of dopexamine in low output congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

A mechanistic role for cardiac myocyte apoptosis in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Apoptosis (the 1992 Frank Rose Memorial Lecture).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Necrotic death as a cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

Evidence of Apoptosis in Arrhythmogenic Right Ventricular Dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00033.2006

10.1152/PHYSIOL.00033.2006

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference